Rapport Therapeutics, Inc.

RAPP

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0002012593

SEC filings (opens in a new tab)

In the last 90 days, Rapport Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Rapport Therapeutics, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of RAPP: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	147	3	160	+16
Shares	52.5M	15.3K	51.3M	−1.20M (−2.3%)
Value	$1.64B	$479.3K	$2.13B	+$488.2M (+29.7%)

3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (28)

Institutions that held Rapport Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to RAPP in Q2 2026
Institution	Shares	Value	% of portfolio
Algert Global LLC	223,822	$9.33M	0.11%
Woodline Partners LP	97,537	$4.06M	0.01%
Citadel Advisors LLC	82,442	$3.44M	0.00%
OrbiMed Advisors LLC	76,616	$3.19M	0.06%
StemPoint Capital LP	66,582	$2.77M	0.48%
Jane Street Group, LLC	55,705	$2.32M	0.00%
Integrated Quantitative Investments LLC	30,386	$1.27M	0.21%
Ellsworth Advisors, LLC	24,539	$979.8K	0.16%
Engineers Gate Manager LP	21,314	$888.2K	0.01%
Legato Capital Management LLC	21,124	$880.2K	0.07%
Sound Capital Solutions LLC	14,606	$608.6K	0.14%
Jupiter Topco LLC	13,800	$574.4K	0.00%
Quadrature Capital Ltd	6,359	$265.0K	0.00%
Profund Advisors LLC	6,358	$264.9K	0.01%
Pictet Asset Management Holding SA	5,198	$216.6K	0.00%
Meeder Asset Management Inc	2,774	$115.6K	0.01%
Aquatic Capital Management LLC	2,112	$88.0K	0.00%
State of Wyoming	1,560	$65.0K	0.01%
Los Angeles Capital Management LLC	771	$32.1K	0.00%
Stone House Investment Management, LLC	211	$8.79K	0.00%
TD Waterhouse Canada Inc.	123	$4.84K	0.00%
Aster Capital Management (DIFC) Ltd	108	$4.50K	0.00%
SRS Capital Advisors, Inc.	54	$2.25K	0.00%
Bare Financial Services, Inc	39	$1.63K	0.00%
Silver Grove Financial Group, Inc.	21	$875	0.00%
National Bank of Canada	7	$291	0.00%
Ameritas Advisory Services, LLC	5	$208	0.00%
Global Retirement Partners, LLC	2	$83	0.00%

Sold out (12)

Institutions that held Rapport Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of RAPP in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Freestone Grove Partners LP	127,783	$4.00M
Sectoral Asset Management Inc	25,421	$835.0K
Soleus Capital Management, L.P.	10,000	$312.9K
Gsa Capital Partners LLP	9,928	$311.0K
Renaissance Technologies LLC	9,700	$303.5K
Verition Fund Management LLC	7,531	$235.6K
Mangrove Partners	6,753	$211.3K
Quantbot Technologies LP	6,493	$203.2K
SG Americas Securities, LLC	3,776	$118.0K
Simplex Trading, LLC	344	$10.8K
Quadrant Capital Group LLC	57	$1.78K
MAI Capital Management	6	$188

Not filed for Q2 2026 yet (3)

Institutions that held Rapport Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RAPP in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Janus Henderson Group PLC	13,800	$432.8K
CWM, LLC	1,475	$46.2K
Sunbelt Securities, Inc.	11	$344